NeuroMetrix, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NURO research report →
Companywww.neurometrix.com
NeuroMetrix, Inc. , a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies.
- CEO
- Shai N. Gozani
- IPO
- 2004
- Employees
- 13
- HQ
- Woburn, MA, US
Price Chart
Valuation
- Market Cap
- $9.43M
- P/E
- -1.16
- P/S
- 3.11
- P/B
- 0.63
- EV/EBITDA
- -0.92
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 55.38%
- Op Margin
- -289.57%
- Net Margin
- -257.38%
- ROE
- -45.38%
- ROIC
- -60.91%
Growth & Income
- Revenue
- $3.03M · -48.61%
- Net Income
- $-7,806,055 · -19.55%
- EPS
- $-3.96 · 36.84%
- Op Income
- $-8,782,037
- FCF YoY
- -13.72%
Performance & Tape
- 52W High
- $4.73
- 52W Low
- $2.66
- 50D MA
- $4.39
- 200D MA
- $4.01
- Beta
- 1.83
- Avg Volume
- 11.50K
Get TickerSpark's AI analysis on NURO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 1, 25 | Horowitz Joshua | sell | 60,500 |
| May 1, 25 | Goodman David | sell | 13,730 |
| May 1, 25 | Goodman David | sell | 7,602 |
| May 1, 25 | Van Avermaete David | sell | 7,601 |
| May 1, 25 | Van Avermaete David | sell | 13,730 |
| May 1, 25 | HIGGINS THOMAS T | sell | 3,308 |
| May 1, 25 | HIGGINS THOMAS T | sell | 11,840 |
| May 1, 25 | KATZ NANCY E | sell | 7,602 |
| May 1, 25 | KATZ NANCY E | sell | 13,730 |
| May 1, 25 | Gozani Shai | sell | 15,466 |
Our NURO Coverage
We haven't published any research on NURO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NURO Report →